Potential therapeutic targets for treatment of the overactive bladder

World Journal of Urology

Volumn 19, Issue 5, 2001, Pages 307-311

  Sellers, Donna J ^a   Chapple, Christopher R ^b   Chess Williams, Russell ^c  

^a SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Overactive bladder a adrenoceptors adrenoceptors tachykinins potassium channels

Indexed keywords

ADRENERGIC ALPHA AGONISTS; ADRENERGIC BETA AGONISTS; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; TACHYKININ;

BLADDER DISEASE; DRUG POTENTIATION; HUMAN; PATHOPHYSIOLOGY; POTASSIUM CHANNEL; REVIEW;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC BETA-AGONISTS; BLADDER DISEASES; HUMAN; POTASSIUM CHANNELS; TACHYKININS;

EID: 0035514758     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00007102     Document Type: Article

References (58)

1. 1. Abelli L, Somma V, Maggi CA, Giuliani S, Geppetti P, Alessandri M, Theodorsson E, Meli A (1988) The contribution of capsaicin-sensitive sensory nerves to xylene-induced visceral pain in conscious, freely moving rats. Naunyn-Schmiedeberg's Arch Pharmacol 337: 545-551
2. Andersson K-E (1992) Clinical pharmacology of potassium channel openers. Pharmacol Toxicol 70: 244-254
3. Andersson K-E (1993) The pharmacology of the lower urinary tract smooth muscles and penile erectile tissues. Pharmacol Rev 45: 253-308
4. Andersson K-E, Appell R, Cardozo LD, Chappie C, Drutz HP, Finkbeiner AE, Haab F, Vela Navarrete R (1999) The pharmacological treatment of urinary incontinence. Br J Urol Int 84: 923-947
5. Buffington CA, Wolfe SA (1998) High affinity binding sites for [3H] substance P in urinary bladders of cats with interstitial cystitis. J Urol 160 (2): 605-611
6. Butera JA, Antane MM, Antane SA, Argentieri TM, Freeden C, Graceffa RF, Hirth BH, Jenkins D, Lennox JR, Matelan E, Norton NW, Quagliato D, Sheldon JH, Spinelli W, Warga D,
7. Wojdan A. Woods M (2000) Design and SAR of novel potassium channel openers targeted for urge urinary incontinence. 1. N-Cyanoguanidine bioisostcres possessing in vivo bladder selectivity. J Med Chem 43 (6): 1 187 1202
8. Castleden CM, Morgan B (1980) The effect of β-adrenoceptor agonists on urinary incontinence in the elderly. Br J Clin Pharmacol 10: 619-620
9. Chess-Williams R, Chappie CR, Verfurlh F, Noble AJ, Couldwell CJ. Michel M (1996) The effects of SB 216469, an antagonist which discriminates between the xiA-adrenoceptor and the human prostatic xradrenoceptor. Br J Pharmacol 1 19: 1093 1100
10. Dion S, D'Oleans-Juste P, Drapeau G, Rhaleb NE, Rouissi N, Tousignant C, Regoli D (1987) Characterisation of neurokinin receptors in various isolated organs by the use of selective agonists. Life Sci 41: 2269-2278
11. Ford APDW, Daniels DV, Chang DJ, Gever JR, Jasper JR, Lesnick JD, Clarke DE (1997) Pharmacological pleiotropism of the human recombinant a|A-adrenoceptor: implications for i-adrenoceptor classification. Br J Pharmacol 121: 1127 1135
12. Gopalakrishnan M, Whiteaker KL, Molinari EJ. Davis-Taber R. Scott VE, Shieh CC, Buckner SA, Milicic I, Cain JC, Post! S, Sullivan .IP. Brioni JD (1999) Characterisation of the ATPsensitive potassium channels (KATP) expressed in guinea pig bladder smooth muscle cells. J Pharmacol Exp Ther 289: 551 558
13. Gruneberger A (1984) Treatment of motor urge incontinence with clenbuterol and flavoxate hydrochloride. Br J Obstet Gynaecol 91: 275 278
14. Guard S. Watson SP (1991) Tachykinin receptor types: classification and membrane signalling mechanisms. Neurochem. Int 18: 149-165
15. Hieble J, Ruffolo R (1997) Recent advances in the identification of a|- and c<2-adrenoceptors subtypes: Therapeutic implications. Exp Opin Invest Drugs 6: 367-387
16. Howe BB, Halterman TJ. Yochim CL, Do ML, Pettinger SJ, Stow RB, Ohnmacht CJ. Rüssel K, Empfield JR, Trainer DA. Brown FJ, Kau ST (1995) ZENECA ZD6169: A novel KATP channel opener with in vivo selectivity for urinary bladder. J Pharmacol Exp Ther 274: 884-890
17. Hu SL, Fink CA, Kim HS, Lappe RW (1997) Novel and potent BK channel openers: COS 7181 and its analogs. Drug Dev Res 41: 10-21
18. Igawa Y, Yamazaki Y, Takeda H, Hayakawa K, Akahane M, Ajisawa T, Yoneyama T, Nishizawa O, Andersson K-E (1999) Functional and molecular biological evidence for a possible β}adrenoceptor in the human detrusor muscle. Br J Pharmacol 126: 819-825
19. Igawa Y, Yamazami Y, Takeda H, Kaidoh K, Akahane M, Ajisawa Y, Yoneyama T, Nishizawa O, Andersson K-E (2001) Relaxation effects of isoproterenol and selective /?3-adrenoceptor agonists on normal, low compliant and hyperreflexic human bladders. J Urol 165: 240-244
20. Ishizuka O, Persson K, Mattiasson A, Naylor A, Wyllie M, Andersson K-E (1996) Micturition in conscious rats with and without bladder outlet obstruction: role of spinal aradrenoceptors. Br J Pharmacol 117: 962-966
21. Jollys JV, Jollys JC, Wilson J, Donovan J, Nanchamel K, Abrams P (1993) Does sexual equality extend to urinary symptoms? Neurourol Urodyn 12: 391-392
22. Langer SZ (1999) History and nomenclature of aradrenoceptors. Eur Urol 36 [Suppl 1]: 2-6
23. Larsen J-J (1979) a- and /2-adrenoceptors in the detrusor muscle and bladder base of the pig and /?-adrenoceptors in the detrusor muscle of man. Br J Pharmacol 65: 215-222
24. Lecci A, Tramontana M, Giuliani S, Criscuoli M, Maggi CA (1998) Effect of tachykinin NK2 receptor blockade on detrusor hyperreflexia induced by bacterial toxin in rats. J Urol 160 (1): 206-209
25. Lepor H, Machi G (1993) Comparison of the AUA symptom index in unselected males and females between 55 and 79 years of age. Urology 42: 36-40
26. Lepor H, Nieder A, Feser J, O'Connell C, Dixon C (1997) Effect of terazosin on prostatism in men with normal and abnormal peak urinary flow rates. Urology 49: 476-480
27. Levin RM, Ruggieri MR, Wein AJ (1988) Identification of receptor subtypes in the rabbit and human urinary bladder by selective radio-ligand binding. J Urol 139: 844-848
28. Lindholm P, Lose G (1986) Terbutaline (Bricanyl) in the treatment of female urge incontinence. Urol Int 41: 158-160
29. Lundberg JM, Saria A (1986) Polypeptide containing neurons in airway smooth muscle. Annu Rev Pharmacol 49: 557-572
30. Maggi CA. Santicioli P. Giuliani S, Regoli D, Meli A (1986) Activation of micturition reflex by substance P and substance K: indirect evidence for the existence of multiple tachykinin receptors in the rat urinary bladder. J Pharmacol Exp Ther 238: 259 266
31. Maggi CA, Giuliani S, Santicioli P, Regoli D, Meli A (1987) Peripheral effects of neurokinins: functional evidence for the existence of multiple receptors. J Autonom Pharmacol 7: 11 32
32. Maggi CA, Geppetti P, Santicioli P, Frilli S, Giuliani S, Furio M. Theodorsson E. Fusco B, Meli A (1988a) Tachykinin-like immuno-reactivity in the mammalian urinary bladder: Correlation with the functions of the capsaicin-sensitive sensory nerves. Neuroscience 26: 233-242
33. Maggi CA. Santicioli P, Patacchini R, Cellerini M, Turinin D, Barbanti G, Beneforti P, Rovero P, Meli A (1988b) Contractile response of the human isolated urinary bladder to neurokinins: involvement of NK-2 receptors. Eur J Pharmacol 145: 335-341
34. Maggi CA, Giuliani S. Santocioli P, Abelli L, Giachetti A (1991) Facilitation of reflex micturition by intravesical administration of [/iAlas]-neurokinin A (4-10), a selective NK2 tachykinin receptor agonist. J Urol 145: 184-187
35. Maggi CA, Patacchini R, Rovero P, Giachetti A (1993) Tachykinin receptors and tachykinin receptor subtypes. J Auton Pharmacol 13: 23-93
36. Maggi CA (1995) Tachykinins and calcitonin gene-related peptide (CGRP) as co-transmitters released from peripheral endings of sensory nerves. Progr Neurobiol 45: 1-98
37. Martin SW. Radley SC, Chess-Williams R, Chappie CR (1997) Relaxant effects of potassium channel openers on normal and hyperreflexic detrusor muscle. Br J Urol 80: 405-413
38. Masuda N. Uchida W, Shirai Y. Shibasaki K, Goto K, Takenaka T (1994) Effects of the potassium channel opener YM 934 on the contractile response to electrical field stimulation in pig detrusor smooth muscle. J Urol 154 (5): 1914-1920
39. Murumatsu I, Oshita M, Ohmura T, Kigoshi S. Akino H, Gobura M, Okada K (1994) Pharmacological characterisation of aradrenoceptor subtypes in the human prostate: Functional and binding studies. Br J Urol 74: 572-578
40. Naglo AS, Nergardh A. Boreua LO (1981) Influence of atropine and isoprenaline on detrusor hyperactivity in children with neurogenic bladder. Scand J Urol Nephrol 15: 97-102
41. Nergardh A, Boreus LO, Naglo A-S (1997) Characterization of the adrenergic beta-receptor in the urinary bladder of man and cat. Acta Pharmacol Toxicol 40: 14-21
42. Noble AJ. Chess-Williams R, Couldwell CJ. Furukawa K, Uchiyama T. Korstanje C, Chappie CR (1997) The effects of tamsulosin, a high-affinity antagonist at functional ac1A- and a,D-adrenoceptor subtypes. Br J Pharmacol 120: 231-238
43. Norlen L, Sundin T, Waggstein F (1978) Effect of betaadrenoceptor stimulation on the human bladder in vivo. Urol Int 33: 355-358
44. Ohmura M, Kondo A, Saito M (1997) Response of isolated human neurogenic bladders to tachykinins. Urologia Internationalis 59 (4): 221-225
45. Oshita M. Hiraoka Y, Watanabe Y (1997) Characterization of β-adrenoceptors in urinary bladder: comparison between rat and rabbit. Br J Pharmacol 122: 1720-1724
46. Pandita RK, Andersson K-E (1999) Effects of intravesical administration of the K+ channel opener, ZD6169. in conscious rats with and without bladder outflow obstruction. J Urol 162: 943 948
47. Perlberg S. Caine M (1982) Adrenergic response of bladder muscle in prostatic obstruction. Urology 20: 524 537
48. Schwinn DA, Price RR (1999) Molecular pharmacology of human a,-adrenergic receptors: unique features of the o-subtype. Eur Urol 36 [Suppl 1]: 7 10
49. Serels S, Stein M (1998) Prospective study comparing hyoscyamine. doxazosin. and combination therapy for the treatment of urgency and frequency in women. Neurourol Urodyn 17: 31-36
50. Shaker HS. Tu LM, Kalfopoulos M. Hassouna M, Dion S. Elhilali M (1998) Hyperrefexia of the urinary bladder: possible role of the efferent function of the capsaicin sensitive primary afférents. J Urol 160 (6 pt 1): 2232-2239
51. Siemer C, Bushfield M, Newgreen D, Grissmer S (2000) Effects of NS 1608 on MaxiK channels in smooth muscle cells from urinary bladder. J Membr Biol 173: 57-66
52. Smet PJ. Moore KH, Jonavicius J (1997) Distribution and (localisation of calcitonin gene-related peptide, tachykinins. and vasoactive intestinal peptide in normal and idiopathic unstable urinary bladder. Lab Invest 77 (1): 37-49
53. Smith DJ. Chappie CR (1994) In vitro response of human bladder smooth muscle in unstable obstructed male bladders: a study of pathophysiological causes. Neurourol Urodyn 13: 14-15
54. Smith MS, Schambra UB. Wilson KH, Page SO. Schwinn DA (1999) 2radrenergic receptors in human spinal cord: specific localized expression of mRNA encoding aradrenergic receptor subtypes at four distinct levels. Mol Brain Res 63: 254-261
55. Wojdan A, Freeden C, Woods M, Oshiro G, Spinclli W, Colatsky TJ. Sheldon JH, Norton NW, Warga D. Antane MM. Antane SA, Butera JA. Argentier! TM (1999) Comparison of the potassium channel openers, WAY-133537, ZD6169, and celikalim on isolated bladder tissue and in vivo bladder instability in rat. J Pharmacol Exp Ther 289 (3): 1410 1418
56. Yu YB, de Groat WC (1998) Effect of ZD6169, a KATp channel opener, on bladder hyperactivity and spinal c-fos expression evoked by bladder irritation in rats. Brain Res 807: 11-18
57. Zeng XP, Moore KH, Burchcr E (1995) Characterisation of tachykinin NK2 receptors in human urinary bladder. J Urol 153 (5): 1688-1692
58. Zhou Q, Sutake N, Shibata S (1995) Inhibitory mechanism of nicorandil in isolated rat urinary bladder and femoral artery. Eur J Pharmacol 273: 153-159